It is our mission to secure Indiana’s position as a global leader in life sciences by advocating, connecting, promoting, and delivering tangible benefits on behalf of our diverse corporate members.

News

As a member benefit, we are pleased to share and highlight member company news! Please send press releases to info@INLifeSciences.org

From Edinburgh to Indy!

Great meeting with lawmakers at the Indiana Statehouse with Sanondaf, one of our Scottish life sciences companies (with U.S. HQ in Indianapolis). Pictured (left to right) Kristin Jones, President & CEO, Indiana Life Sciences Association; Rep. Justin Busch (R) Dist. 16; Gov. Mike Braun; Stuart White, CEO, Sanondaf UK and James Bogner, President, Sanondaf North America.

Kimball Electronics Opens New Indianapolis Facility

On February 6, 2026, Kimball executives, local officials, and community leaders gathered at the new facility located at 1220 Post Road, Indianapolis, IN, to celebrate the opening of Kimball’s advanced manufacturing and innovation hub serving the medical and life sciences industries. Read more.

Members connect – New ILSA members Wake Scientific showcased their Indianapolis repair/maintenance facility to Sanondaf’s CEO and US President.

Pictured (left to right) Stuart White, Sanondaf; Joe Arteaga, Wake Scientific; Jason Nicoluzakis, Wake Scientific and Jim Bogner, Sanondaf.

State Announces New $21 Million+ Early-Stage Fund

Indiana Governor Mike Braun today announced the launch of Crossroads Health Ventures (CHV), a new early-start venture fund designed to accelerate the growth of Indiana’s life sciences startups and strengthen the state’s global leadership across human, animal and plant health innovation.Read more.

Tecomet and Orchid Orthopedic Solutions to Merge

Tecomet and Orchid Orthopedic Solutions have entered into a definitive agreement to merge, bringing together complementary capabilities to increase capacity, expand their reach and support long-term growth for the company. The merger combines two of the largest contract manufacturers in the orthopedic space and will likely have a profound impact on the supply chains of the top OEMs.

SpectronRx completes expansion of Bunker Hill campus

Indianapolis-based radiopharmaceutical company SpectronRx is celebrating the completion of a major expansion at its campus near Grissom Air Reserve Base in Bunker Hill. While the company is not disclosing its investment in the expansion, the project included the acquisition of 14 additional acres and the construction of a new, 150,000-square-foot production facility. Read more.

BIO Business Solutions is about much more than lab equipment! Need office supplies and services? Take a look at ODP Business Solutions

• Heavily discounted Core List and ability to add custom core
• Special pricing on HP Ink and Toner
• Up to 49% on more than 140,000 sku off the ODP web prices
• Free Shipping on orders over $30

NEW BUY-IN PURCHASING PROGRAM

NEW FEATURED PROGRAM: Pintail Solutions

Pintail Solutions will complete a no-cost assessment of your people, process, and technology to uncover gaps that may be blocking the delivery of your business strategy.

We focus on questions like:

• Is the leadership team fully aligned on the organizational goals and KPIs?
• Do their employees understand how their work connects to those goals?
• Are your processes and tools enabling or hindering strategic delivery?

Improved clarity and alignment around goals and metrics drives productivity; connecting employee deliverables to the broader ‘why’ strengthens morale and execution; ensuring processes and tools are ‘fit for purpose’ enables operational excellence.

Policy Updates

BIO celebrates passage of PPRV reauthorization and PBM reforms

BIO celebrated inclusion of two of its legislative priorities in the spending package passed on Feb. 3: reauthorization of the Pediatric Priority Review Voucher (PPRV) and pharmacy benefit manager (PBM) reform.

The PPRV program was reauthorized until 2029.

BIO’s view: “The PPRV program provides critical incentives for rare disease research, and its reauthorization provides stability and confidence for biotech innovators who are leading the way in the discovery of breakthrough treatments,” said a statement from BIO President & CEO John F. Crowley hailing the “bipartisan victory for children and families living with rare diseases.”

The first major federal PBM reforms in decades prevent PBM compensation from being linked to the list price of a drug and add measures to increase PBM transparency.

BIO’s view: “This funding package also takes important first steps to rein in Pharmacy Benefit Managers (PBMs),” Crowley said. “For too long, these middlemen have driven up costs for patients.”

Read more on Bio News.

MCED Act Passes

Following a six-year effort, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, has been officially signed into law - marking one of the most significant cancer policy advancements in years. Medicare beneficiaries will now have access to multi-cancer early detection (MCED) screening technologies once they receive FDA approval. This represents a critical step forward in the fight against cancer and holds particular promise for rural and underserved communities, where access to timely screening has too often been limited.

Read The Prevent Cancer Foundation’s statement here.

America's Biotech Leadership Depends on the States

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments. All states should consider impactful biotech policies that grow and strengthen our domestic biotechnology industry. If states fail to utilize and replicate what are considered to be the best and most successful policies in biotech-focused economic development, the United States will soon lose its long-term leadership in developing medicines and medical technologies, which underpin our health, our economy, and our national security. Read more.

New Members

Be sure to check out our Member Directory featuring company descriptions and an alphabetical listing.

Bright Sheet Metal Co. Inc provides commercial HVAC, sheet metal fabrication, and duct work services to the Indianapolis IN, area.

W. Triplett Consulting LLC is an advisor and advocate to the sterile compounding industry.

Abingdon Health Group is a leading med-tech contract service provider offering its services to an international customer base.

The Group’s CDMO (Contract Development and Manufacturing Organisation) expertise offers lateral flow product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format.

For over 35 years, Midwest Institute for Clinical Research® (MICR®) is a private research organization established in the summer of 1988 to develop and implement clinical trials in the Indianapolis metropolitan area. With over 550 protocols performed, their research program is dedicated to provide the highest quality service to both the pharmaceutical and medical device industry as well as to the volunteers who participate in these clinical trials. MICR® is a trusted, and established research company committed to clinical research in the Indianapolis area. It has the experience, resources, and sensitivity to the volunteers that provides the comprehensive service pharmaceutical and medical device industry looks for in a research partner. The concern for detail and quality has distinguished MICR® as a premier research organization typically exceeding all sponsor and FDA requirements.

Thrive Orthopedics is a medical device manufacturer specializing in carbon fiber orthotics, prosthetics, and other durable medical equipment for orthopedics, rehabilitation, and sports medicine.

DeHeer Orthopedics is a family owned medical device company that specializes in developing and manufacturing innovative surgical solutions for the lower extremity.

Wilhelm excels in providing a variety of construction services, ensuring superior quality control, enhanced project efficiency, and exceptional value. Our capabilities include General Construction, Design-Build, Preconstruction, and Construction Management. From ground-up builds and renovations to integrated design-build services, meticulous preconstruction planning, and comprehensive construction management, we handle every aspect with precision and excellence.

BioCrossroads is a catalyst for Indiana’s diverse and growing life sciences industry, supporting collaboration, expertise, and investments that fuel innovation and transform global health.

Your business deserves a team that understands it. First Financial Bank's tools and services provide your business with the things it needs to win, all with the support of a banking team that’s local to you.

The NuTech Team has experience from all areas of the O&P profession – clinical, research, sales, marketing, clinical patient care, reimbursement, manufacturing, and more. Their unique team has well over 200 years of experience in the O&P industry.

Tuesday, February 17, 2026

11:30 a.m. - 1:00 p.m.

Barnes & Thornburg LLP

11 S. Meridian Street, Indianapolis, IN 46204

Registration coming soon!

Ask Us Anything: Life Sciences Edition 

This month’s panel brings together who field some of the most common – and consequential – questions from Indiana life sciences companies. The group will share the issues they hear most often from entrepreneurs, manufacturers, and growing firms across the sector.  

From navigating capital and credit, to understanding regulatory and market pressures, to accessing technical assistance and statewide resources, the panel will offer a candid, practical look at the challenges and opportunities shaping company decisions in today’s life sciences landscape.

• Dan Drexler, Regional Director, Central Indiana Small Business Development Center
• Michael Luebcke, Indiana District Leader, First Financial Bank
• Kristin Jones, President and CEO, IN Life Sciences Association

• Welcome: Deborah Pollack-Milgate, Partner, Barnes & Thornburg 
• Moderator: Jeremy Brilliant, fractional Chief Marketing Officer, Indiana Life Sciences Association

Biocom Global Partnering and Investor Conference
February 24 – 26, 2026 | The Lodge at Torrey Pines, La Jolla

This exclusive partnering and investor forum brings together over 500 investors and senior executives, including CEOs and heads of business development, biotech, and research and development from leading pharmaceutical, biotech, and research organizations from over 20 countries. This prestigious conference features panel discussions, one-on-one partnering meetings, presentations from small companies and leading research institutions, and endless networking opportunities.

On The Hunt for What’s Next: Sources of Innovation
February 27, 2026 | Indiana Biosciences Research Center

1st Floor Conference Center | 1:30 p.m. to 4 p.m.

As the industry becomes more and more competitive, in addition to their own operations, firms are also looking outside to help grow sales or find the next big new product. This can take various forms like deals with private equity owned or venture capital funded firms, deeper collaborations with universities, partnerships with compounding centers, and new sales channels aimed directly at consumers. Close observers and “those in the trenches” will provide their latest thinking and discuss how even within a segment of the industry the approach to innovate may vary.

March 2-3, 2026 | BIO Investment & Growth Summit

Miami Beach

The BIO Investment & Growth Summit (BIG Summit) is a new event organized by BIO designed to help biotech leaders, investors, and innovators navigate the path to sustainable growth.

Join us in Miami Beach, March 2-3, 2026, for two days of high-impact programming, strategic networking, and forward-looking discussions built to help your company thrive. You’ll gain insights from top minds in biotechnology, explore the financial and policy trends shaping the industry, and make valuable connections through BIO Partnering™ and dedicated networking opportunities.

Whether you’re advancing your company’s next stage of growth or seeking your next investment opportunity, the BIG Summit delivers the direction, expertise, and partnerships you need to move forward.

March 4, 2026 | Indy BioBridge Q1 Mixer

4:30 p.m. | Ossium Health 5742 West 74th Street, Indianapolis, IN 46278

Join us for a fun evening at the Indy BioBridge Q1 Mixer - panel discussion, networking, refreshments, and great conversations await! This event will include:

• Panel discussion led by industry professionals
• Beer & Wine (as well as non-alcoholic refreshments).
• 2 Tickets included with your RSVP, cash bar for additional beverages
• Light bites
• Open floor networking
• Opportunities to tour Ossium's state of the art facility and learn more about the innovative work they are doing behind their doors.

Join the IN Life Sciences Association

Become a Member Today!

Time to renew? Try it on-line! It's quick and easy! Members can renew their memberships on-line at any time and update information in the Member Directory. Not a Member yet? Join today!